Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-599-3 | CAS number: 18820-29-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Inhalation: The particle size distribution test indicates that inhalation is a possible route of exposure. However, an investigation on the bioavailability of the registered substance in artificial lung fluid demonstrates the very low bioavailability of the substance (see Andersen K, section 7.12). To support this, MnS is not acutely toxic by the oral route (IUCLID section 7.2.1) and not acutely harmful by the inhalation route (IUCLID section 7.2.2). A literature review of available human and animal data on reproductive toxicity to manganese-based compounds (Furnes B and Strupp C, (2009) MANGANESE AND ITS INORGANIC COMPOUNDS: 1. REPROTOXICITY ASPECTS) showed equivocal evidence of reproductive toxicity with no report or incidence on MnS specifically. The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds.Therefore, taking into account both the very low bioavailability of MnS and animal welfare, this test is not considered scientifically necessary in accordance with Annex XI, section 1.1.
Dermal: The registered substance is very poorly water soluble (IUCLID section 4.8); hence minimal amount of the potential substance is made available for systemic absorption via the dermal route. Even if minimally available from exposure, the physiological properties of the registered substance do not indicate a significant rate of absorption through the skin and this is supported by the result of the study on MnCl2 (see IUCLID section 7.1.2, which showed only 0.79% available Mn was absorbed). Furthermore, there were no systemic effects or any other evidence of absorption seen in the skin and eye irritation studies (IUCLID section 7.3). The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds. Moreover, this is not the most likely route of systemic exposure. Therefore, according to Column 2, Section 8.6 of Regulation No 1907/2006, this test is not considered necessary.
Oral: MnS is used in industrial settings where good industrial hygiene is employed. Exposure via the oral route is therefore implausible. Therefore, this is not a likely route of exposure. However, in the unlikely event of accidental consumption, the acute oral toxicity test for MnS (IUCLID 5 section 7.2.1) confirms no evidence of toxicity via this route. The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds. Therefore in accordance with Annex XI section 1.1, this test is not considered necessary.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- Inhalation: The particle size distribution test indicates that inhalation is a possible route of exposure. However, an investigation on the bioavailability of the registered substance in artificial lung fluid demonstrates the very low bioavailability of the substance (see Andersen K, section 7.12). To support this, MnS is not acutely toxic by the oral route (IUCLID section 7.2.1) and not acutely harmful by the inhalation route (IUCLID section 7.2.2). A literature review of available human and animal data on reproductive toxicity to manganese-based compounds (Furnes B and Strupp C, (2009) MANGANESE AND ITS INORGANIC COMPOUNDS: 1. REPROTOXICITY ASPECTS) showed equivocal evidence of reproductive toxicity with no report or incidence on MnS specifically. The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds.Therefore, taking into account both the very low bioavailability of MnS and animal welfare, this test is not considered scientifically necessary in accordance with Annex XI, section 1.1.
Dermal: The registered substance is very poorly water soluble (IUCLID section 4.8); hence minimal amount of the potential substance is made available for systemic absorption via the dermal route. Even if minimally available from exposure, the physiological properties of the registered substance do not indicate a significant rate of absorption through the skin and this is supported by the result of the study on MnCl2 (see IUCLID section 7.1.2, which showed only 0.79% available Mn was absorbed). Furthermore, there were no systemic effects or any other evidence of absorption seen in the skin and eye irritation studies (IUCLID section 7.3). The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds. Moreover, this is not the most likely route of systemic exposure. Therefore, according to Column 2, Section 8.6 of Regulation No 1907/2006, this test is not considered necessary.
Oral: MnS is used in industrial settings where good industrial hygiene is employed. Exposure via the oral route is therefore implausible. Therefore, this is not a likely route of exposure. However, in the unlikely event of accidental consumption, the acute oral toxicity test for MnS (IUCLID 5 section 7.2.1) confirms no evidence of toxicity via this route. The SCOEL (SUM/127;2011) state that there is little evidence for reprotoxicity for manganese and its inorganic compounds. Therefore in accordance with Annex XI section 1.1, this test is not considered necessary. - Endpoint:
- extended one-generation reproductive toxicity - basic test design (Cohorts 1A, and 1B without extension)
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Reproductive effects observed:
- not specified
Referenceopen allclose all
Effects on developmental toxicity
Description of key information
Inhalation: The particle size distribution test indicates that inhalation is a possible route of exposure . However, an investigation on the bioavailability of the registered substance in artificial lung fluid demonstrates the very low bioavailability of the substance (see Andersen K, section 7.12). To support this, MnS is not acutely toxic by the oral route (IUCLID section 7.2.1) and not acutely harmful by the inhalation route (IUCLID section 7.2.2). A literature review of available human and animal data on reproductive toxicity to manganese-based compounds (Furnes B and Strupp C, (2009) MANGANESE AND ITS INORGANIC COMPOUNDS: 1. REPROTOXICITY ASPECTS) showed equivocal evidence of reproductive toxicity with no report or incidence on MnS specifically. The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Therefore, taking into account both the very low bioavailability of MnS and animal welfare, this test is not considered scientifically necessary in accordance with Annex XI, section 1.1.
Dermal: The registered substance is very poorly water soluble (IUCLID section 4.8); hence minimal amount of the potential substance is made available for systemic absorption via the dermal route. Even if minimally available from exposure, the physiological properties of the registered substance do not indicate a significant rate of absorption through the skin and this is supported by the result of the study on MnCl2 (see IUCLID section 7.1.2, which showed only 0.79% available Mn was absorbed). Furthermore, there were no systemic effects or any other evidence of absorption seen in the skin and eye irritation studies (IUCLID section 7.3). The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Moreover, this is not the most likely route of systemic exposure. Therefore, according to Column 2, Section 8.6 of Regulation No 1907/2006 , this test is not considered necessary.
Oral: MnS is mostly used in industrial settings where good industrial hygiene is employed. Outside these industrial settings, the registered substance is used by trained professionals. Exposure via the oral route is therefore implausible. Therefore, this is not a likely route of exposure. However, in the unlikely event of accidental consumption, the acute oral toxicity test for MnS (IUCLID 5 section 7.2.1) confirms no evidence of toxicity via this route. The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Therefore in accordance with Annex XI section 1.1, this test is not considered necessary.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- Inhalation: The particle size distribution test indicates that inhalation is a possible route of exposure . However, an investigation on the bioavailability of the registered substance in artificial lung fluid demonstrates the very low bioavailability of the substance (see Andersen K, section 7.12). To support this, MnS is not acutely toxic by the oral route (IUCLID section 7.2.1) and not acutely harmful by the inhalation route (IUCLID section 7.2.2). A literature review of available human and animal data on reproductive toxicity to manganese-based compounds (Furnes B and Strupp C, (2009) MANGANESE AND ITS INORGANIC COMPOUNDS: 1. REPROTOXICITY ASPECTS) showed equivocal evidence of reproductive toxicity with no report or incidence on MnS specifically. The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Therefore, taking into account both the very low bioavailability of MnS and animal welfare, this test is not considered scientifically necessary in accordance with Annex XI, section 1.1.
Dermal: The registered substance is very poorly water soluble (IUCLID section 4.8); hence minimal amount of the potential substance is made available for systemic absorption via the dermal route. Even if minimally available from exposure, the physiological properties of the registered substance do not indicate a significant rate of absorption through the skin and this is supported by the result of the study on MnCl2 (see IUCLID section 7.1.2, which showed only 0.79% available Mn was absorbed). Furthermore, there were no systemic effects or any other evidence of absorption seen in the skin and eye irritation studies (IUCLID section 7.3). The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Moreover, this is not the most likely route of systemic exposure. Therefore, according to Column 2, Section 8.6 of Regulation No 1907/2006 , this test is not considered necessary.
Oral: MnS is mostly used in industrial settings where good industrial hygiene is employed. Outside these industrial settings, the registered substance is used by trained professionals. Exposure via the oral route is therefore implausible. Therefore, this is not a likely route of exposure. However, in the unlikely event of accidental consumption, the acute oral toxicity test for MnS (IUCLID 5 section 7.2.1) confirms no evidence of toxicity via this route. The SCOEL (SUM/127;2011) state that there is little evidence for development toxicity for manganese and its inorganic compounds. Therefore in accordance with Annex XI section 1.1, this test is not considered necessary. - Species:
- rabbit
- Abnormalities:
- not specified
- Developmental effects observed:
- not specified
Reference
Justification for classification or non-classification
Classification via the inhalation route is not justified because the bioavailability of MnS in artificial lung fluid demonstrates the low bioavailability of the substance (IUCLID section 7.12, Anderson KA). To support this, MnS not acutely harmful by the inhalation route ( IUCLID section 7.2.2, Griffiths DR). A literature review of available human and animal data on reproductive toxicity to manganese-based compounds showed equivocal evidence of reproductive toxicity with no report or incidence on MnS specifically.
Classification via the dermal route is not justified because MnS is only slightly water soluble (IUCLID section 4.8, O'Connor and Mullee), hence minimal amount of the potential substance is made available for systemic absorption via the dermal route. Even if minimally available from exposure, the physiological properties of MnS do not indicate a significant rate of absorption through the skin. Furthermore, there were no systemic effects or any other evidence of absorption seen in the skin and eye irritation studies IUCLID section 7.3, Warren N) .
Classification via the oral route is not justified because MnS is mostly used in industrial settings where good industrial hygiene is employed. Outside these industrial settings, the registered substance is used by trained professionals. Exposure via the oral route is therefore implausible. Therefore, this is not a likely route of exposure. However, in the unlikely event of accidental consumption, the acute oral toxicity test for MnS (IUCLID section 7.2.1, Pooles A) confirms no evidence of toxicity via this route. Low oral absorption of Mn due to the homeostatic mechanism, further supports this justification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.